Publication | Closed Access

Newly developed glycogen synthase kinase-3 (GSK-3) inhibitors protect neuronal cells death in amyloid-beta induced cell model and in a transgenic mouse model of Alzheimer’s disease

Neurodegenerative DiseasesAlzheimer's DiseaseCell DeathDegenerative PathologyNeuroprotectionNeuroscienceNeurologyNeurodegenerationTransgenic Mouse ModelMedicineCell BiologyNeuronal Cells DeathGlycogen Synthase Kinase-3Protective MechanismsNeuroinflammation